Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Original Discovery was a specialized drug discovery company based in Oxford, UK, that focused on leveraging human genetics and large-scale data science to identify and validate novel therapeutic targets. Founded by prominent industry figures, including Dr. Jonathan Knowles (former Head of R&D at Roche), the company aimed to bridge the gap between genomic insights and clinical drug development. Its approach involved analyzing complex genetic datasets to uncover the underlying biological drivers of disease, particularly in areas with high unmet medical needs. Although the company operated primarily in a stealth or semi-stealth mode, it was recognized for its high-caliber leadership and its focus on data-driven target prioritization. Original Discovery Limited was officially dissolved in early 2021.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Original Discovery.